InvestorsHub Logo
Followers 122
Posts 6384
Boards Moderated 0
Alias Born 08/17/2014

Re: Rkmatters post# 62460

Friday, 05/20/2016 3:19:59 PM

Friday, May 20, 2016 3:19:59 PM

Post# of 706927
I want to add that it doesn't mean the DCVax-Direct+CI combination won't be effective. I just think there are only so many things they can invest in, and from a strategic standpoint, partnering with cheaper has-seen success technology will be the initial route that big Pharma takes. And thus it will be up to NW Bio to create their own combination pathway. Buying exclusive licensing rights to a CI is such an avenue; and in the long run it could be the one that makes the company much more revenue $$$. No two checkpoints are exactly the same; and negotiating with a different MOA CI could mean that patients benefit from prior or post immunotherapy interacting with DCVax Direct as they will not have to turn prior therapy patients away.

Anyway, just me $.02 in it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News